Author

C. Stubben

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Organism:human· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:gene regulatory network inference· 2

Frequent Co-Authors

A. H. Grossmann· 1 shared A. Jones· 1 shared A. Lex· 1 shared A. Rogers· 1 shared B. K. Lohman· 1 shared B. Lohman· 1 shared B. T. Spike· 1 shared C. P. Rich· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. H. Grossmann

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.

Y. Wee, J. Wang, E. C. Wilson, C. P. Rich, A. Rogers, Z. Tong, E. DeGroot, Y. N. V. Gopal, M. A. Davies, H. A. Ekiz, J. K. H. Tay, C. Stubben, K. M. Boucher, J. M. Oviedo, K. Fairfax, , A. H. Grossmann

This study identifies ARF6-dependent endocytic trafficking of the IFN-gamma receptor as a mechanism driving adaptive immune resistance in cancer, linking it to immune checkpoint blockade efficacy.

bioRxiv · Sep 29, 2023Cancer Biology

FoxA1 and FoxA2 regulate growth and cellular identity in NKX2-1-positive lung adenocarcinoma

G. Orstad, G. Fort, T. J. Parnell, A. Jones, C. Stubben, B. Lohman, K. L. Gillis, W. Orellana, R. Tariq, O. Klingbeil, K. H. Kaestner, C. Vakoc, B. T. Spike, E. L. Snyder

This study shows that FoxA1/2 are critical for tumorigenesis and cellular identity in NKX2-1-positive lung adenocarcinoma, with their loss impairing tumor growth and altering transcriptional programs.

bioRxiv · Jun 29, 2021 · PreprintCancer Biology

Bidirectional interconversion between mutually exclusive tumorigenic and drug-tolerant melanoma cell phenotypes

Y. Zhang, R. L. Belote, M. A. Urquijo, M. M. Hansen, M. Hejna, T. E. Moustafa, T. Liu, D. Lange, F. Vand-Rajabpour, M. Chang, B. K. Lohman, C. Stubben, X. Zhang, L. S. Weinberger, M. W. VanBrocklin, , R. L. Judson-Torres

This study identifies bidirectional interconversion between tumorigenic and drug-tolerant melanoma cell states through BRN2 expression, revealing distinct molecular programs and therapeutic implications.

bioRxiv · Aug 26, 2020 · PreprintCancer Biology

Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4

S. A. Camolotto, V. Belova, L. Torre-Healy, J. Vahrenkamp, K. Berrett, H. Conway, C. Stubben, R. Moffitt, J. Gertz, E. Snyder

This study shows HNF4α suppresses PDAC growth and promotes the Classical subtype by repressing SIX1/4, which are critical for Basal-like subtype proliferation.

bioRxiv · Oct 22, 2019Cancer Biology